The Orbit SDS developed by Gyroscope Therapeutics uses a flexible cannula designed to contour to the globe and access the back of the eye, targeting a subretinal location in the posterior segment.
The procedure enables precise infusate delivery to the subretinal space without removing the vitreous or creating a retinotomy.
The Orbit SDS was specifically designed and optimized for precise microinjection into the subretinal space.
Controlled infusate delivery to the subretinal space.
Volume: This procedure enables delivery of a precise infusate dosage to the subretinal space and eliminates efflux into the vitreous.
Location: The Orbit SDS delivers the dose in close proximity to the target subretinal location.
Reproducible procedure delivering intentional results.
The Orbit SDS was designed to reduce intraoperative variabilities and provide for a standardized subretinal delivery procedure.
Avoids potential vitrectomy-related complications.
This procedure allows the surgeon to directly enter the subretinal space and does not require removal of the healthy vitreous.
*Please refer to the Instructions for Use for a detailed review of procedure steps and associated procedure risks associated with the Orbit Subretinal Delivery System.
Chang S. LXII Edward Jackson lecture: open angle glaucoma after vitrectomy. Am J Ophthalmol. 2006;141(6):1033-1043.
Hindawi Journal of Ophthalmology Volume 2020, Article ID 5085180, Incidence and Risk Factors of Iatrogenic Retinal Breaks 20-Gauge versus 25-Gauge Vitrectomy for Idiopathic Macular Hole Repair.